PEPE, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 1.212
EU - Europa 804
AS - Asia 602
AF - Africa 14
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.637
Nazione #
US - Stati Uniti d'America 1.198
IT - Italia 511
SG - Singapore 294
HK - Hong Kong 212
DE - Germania 78
CN - Cina 60
NL - Olanda 43
ES - Italia 35
FI - Finlandia 32
GB - Regno Unito 27
IN - India 18
IE - Irlanda 16
UA - Ucraina 16
CA - Canada 12
CI - Costa d'Avorio 11
FR - Francia 9
RU - Federazione Russa 8
JP - Giappone 6
SE - Svezia 5
BE - Belgio 4
GR - Grecia 4
RS - Serbia 4
PK - Pakistan 3
RO - Romania 3
VN - Vietnam 3
AR - Argentina 2
BR - Brasile 2
MX - Messico 2
PL - Polonia 2
AT - Austria 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
EE - Estonia 1
EG - Egitto 1
EU - Europa 1
HR - Croazia 1
IR - Iran 1
KR - Corea 1
KZ - Kazakistan 1
MA - Marocco 1
MD - Moldavia 1
NO - Norvegia 1
NP - Nepal 1
SC - Seychelles 1
TR - Turchia 1
TW - Taiwan 1
Totale 2.637
Città #
Chandler 248
Singapore 243
Hong Kong 212
Santa Clara 103
Naples 69
Ashburn 55
Milan 55
Lawrence 53
Millbury 53
Des Moines 42
Rome 36
Napoli 34
Amsterdam 31
Valencia 30
Boston 24
Helsinki 24
Munich 19
Wilmington 18
Beijing 17
Fairfield 12
Seattle 12
Bologna 11
Nanjing 11
Ottawa 11
Florence 10
Turin 9
Falkenstein 8
Aversa 7
Dublin 7
Krefeld 7
Princeton 7
Kronberg 6
Lappeenranta 6
Redwood City 6
Viareggio 6
Bari 5
Council Bluffs 5
Frankfurt am Main 5
Genoa 5
Guangzhou 5
Houston 5
Salerno 5
Woodbridge 5
Bagnoli Irpino 4
Belgrade 4
Chieti 4
Cilavegna 4
Hangzhou 4
London 4
Los Angeles 4
Moscow 4
Sciacca 4
Bad Durrheim 3
Berlin 3
Casalnuovo di Napoli 3
Ercolano 3
Fisciano 3
Grosseto 3
Karachi 3
Montalto di Castro 3
Monza 3
Nanchang 3
Pamplona 3
Pune 3
Salt Lake City 3
Scafati 3
Shanghai 3
Shenyang 3
Venaria Reale 3
Agrate Brianza 2
Arezzo 2
Atlanta 2
Avellino 2
Boardman 2
Borgomanero 2
Brindisi 2
Brussels 2
Cagliari 2
Carpi 2
Casapulla 2
Castellammare Di Stabia 2
Cava Manara 2
Cernobbio 2
Chiaramonte Gulfi 2
Chions 2
Copparo 2
Dallas 2
Dragoni 2
Ferrara 2
Foggia 2
Giugliano in Campania 2
Hebei 2
Ho Chi Minh City 2
Marano Di Napoli 2
Marigliano 2
Melito Di Napoli 2
Mercogliano 2
Monte Roberto 2
Montello 2
Munro 2
Totale 1.691
Nome #
Performance analysis of SiRe next-generation sequencing panel in diagnostic setting: focus on NSCLC routine samples 100
ESR1 mutations in HR+/HER2-metastatic breast cancer: Enhancing the accuracy of ctDNA testing 91
Setting up and exploitation of a nano/technological platform for the evaluation of HMGA1b protein in peripheral blood of cancer patients 68
Liquid biopsy as indication of tumour progression in lung cancer: A potential intervention in tertiary prevention 58
ALK and ROS1 testing on lung cancer cytologic samples: Perspectives 55
Cell free DNA analysis by SiRe® next generation sequencing panel in non small cell lung cancer patients: focus on basal setting. 55
Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients 54
Antitumor efficacy of dual blockade of EGFR signaling by osimertinib in combination with selumetinib or cetuximab in activated EGFR human NSCLC tumor models. 49
Predictive molecular pathology in metastatic thyroid cancer: the role of RET fusions 49
Liquid biopsy for BRAF mutations testing in non-small cell lung cancer: A retrospective study 46
Evaluation of the Molecular Landscape in PD-L1 Positive Metastatic NSCLC: Data from Campania, Italy 44
Dealing with NSCLC EGFR mutation testing and treatment: A comprehensive review with an Italian real-world perspective 44
Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study 43
In-house homologous recombination deficiency testing in ovarian cancer: a multi-institutional Italian pilot study 42
Mismatch repair proteins and microsatellite instability in solid pseudopapillary neoplasm of the pancreas 41
Liquid Biopsy Analysis in Clinical Practice: Focus on Lung Cancer 41
Next Generation Sequencing for liquid biopsy based testing in Non-Small Cell Lung Cancer in 2021 38
Brca1/2 ngs somatic testing in clinical practice: a short report 37
Multiplex digital colour-coded barcode technology on RNA extracted from routine cytological samples of patients with non-small cell lung cancer: pilot study 36
Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR 36
Harmonization of Next-Generation Sequencing Procedure in Italian Laboratories: A Multi-Institutional Evaluation of the SiRe® Panel 36
Cytology meets next generation sequencing and liquid biopsy: A case of lung adenocarcinoma presenting as metastasis to the phalanx 35
RNA-Based Assay for Next-Generation Sequencing of Clinically Relevant Gene Fusions in Non-Small Cell Lung Cancer 35
Methods for actionable gene fusion detection in lung cancer: now and in the future 35
Concomitant Rare KRAS and BRAF Mutations in Lung Adenocarcinoma: A Case Report 35
Liquid Biopsy in Prostate Cancer Management{\textemdash}Current Challenges and Future Perspectives 34
Unusual Clinical Experience in BRAF Exon 15 p.K601E-Mutated Lung Cancer: A Case Report and Brief Review of the Literature 33
EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: A case report and literature review 33
KRAS mutations testing in non-small cell lung cancer: The role of Liquid biopsy in the basal setting 33
Multi-gene custom panels for the characterisation of metastatic colorectal carcinoma in clinical practice: express the role of PIK3CA mutations 33
KRAS, NRAS and BRAF mutations detected by next generation sequencing, and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy 32
Predictive molecular pathology in the time of COVID-19 32
The role of liquid biopsy in epithelial ovarian cancer: state of the art 31
Comparison between two different next generation sequencing platforms for clinical relevant gene mutation test in solid tumours 31
BRAF: A Two-Faced Janus 31
Fine-Needle Aspiration Is Suitable for Breast Cancer BRCA Molecular Assessment: A Case Report 31
Standardized and simplified reporting of next-generation sequencing results in advanced non-small-cell lung cancer: practical indications from an Italian multidisciplinary group 31
PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories 30
Comparison of two next-generation sequencing-based approaches for liquid biopsy analysis in patients with non-small cell lung cancer: a multicentre study 30
Critical aspects of MSI testing in endometrial cancer: a comparison study 30
Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting 30
Next generation sequencing in cytology 30
Pharmacodynamics of current and emerging PD-1 and PD-L1 inhibitors for the treatment of non-small cell lung cancer 29
EGFR T790M detection rate in lung adenocarcinomas at baseline using droplet digital PCR and validation by ultra-deep next generation sequencing 28
Next Generation Sequencing in Cytopathology: Focus on Non-Small Cell Lung Cancer 28
Molecular Testing of Thyroid Fine-Needle Aspiration: Local Issues and Solutions. An Interventional Cytopathologist Perspective 28
RNA-based next generation sequencing in non-small-cell lung cancer in a routine setting: an experience from an Italian referral center 27
Circulating tumor DNA in cancer: Predictive molecular pathology meets mathematics 27
Evaluation of a novel liquid biopsy-based ColoScape assay for mutational analysis of colorectal neoplasia and triage of FIT+ patients: a pilot study 26
Next generation sequencing identifies novel potential actionable mutations for grade I meningioma treatment 25
Tumor mutational burden on cytological samples: A pilot study 25
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience 25
An Italian Multicenter Perspective Harmonization Trial for the Assessment of MET Exon 14 Skipping Mutations in Standard Reference Samples 24
DNA-Based Sequencing Assays 24
MMR profile and microsatellite instability status in colorectal mucinous adenocarcinoma with synchronous metastasis: a new clue for the clinical practice 24
Microsatellite instability evaluation of patients with solid tumour: routine practice insight from a large series of Italian referral centre 24
Prevalence of KRAS, NRAS and BRAF mutations detected by massive parallel sequencing and differential clinical outcome in metastatic colorectal cancer (MCRC) patients (pts) treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy 23
The evolving role of liquid biopsy in lung cancer 23
The development of a narrow target gene panel makes next generation sequencing effective for circulating free DNA analysis 23
Osimertinib 23
TargetPlex FFPE-Direct DNA Library Preparation Kit for SiRe NGS panel: an international performance evaluation study 23
The biomarkers ATLAS: An audit on 1100 non-small cell lung cancer from an Italian knowledge-based database 22
Uterine Tumours Resembling Ovarian Sex-Cord Tumors: A Case Report and Review of the Literature 22
A narrative review on the implementation of liquid biopsy as a diagnostic tool in thoracic tumors during the COVID-19 pandemic 22
Standardized molecular pathology workflow for ctDNA-based ESR1 testing in HR+/HER2- metastatic breast cancer 20
Microsatellite instability evaluation by automated microfluidic electrophoresis: an update 20
Clinical Multigene Panel Sequencing Identifies Distinct Mutational Association Patterns in Metastatic Colorectal Cancer 20
Technical Validation of a Fully Integrated NGS Platform in the Real-World Practice of Italian Referral Institutions 19
The role of molecular heterogeneity targeting resistance mechanisms to lung cancer therapies 19
Predictive biomarkers for molecular pathology in lung cancer 18
The significance of epidermal growth factor receptor uncommon mutations in non-small cell lung cancer: A systematic review and critical appraisal 18
Differential clinical outcome according to KRAS, NRAS and BRAF genotype detected by massive parallel sequencing of metastatic colorectal cancer patients treated with first line FIr-B/FOx adding bevacizumab to triplet chemotherapy 17
Universal Markers Unveil Metastatic Cancerous Cross-Sections at Nanoscale 16
RAS as a positive predictive biomarker: focus on lung and colorectal cancer patients 16
Reference standards for gene fusion molecular assays on cytological samples: an international validation study 16
The significance of tissue-agnostic biomarkers in solid tumors: the more the merrier? 15
Next generation diagnostic algorithm in non-small cell lung cancer predictive molecular pathology: The KWAY Italian multicenter cost evaluation study 15
The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials 15
Nanoscale Prognosis of Colorectal Cancer Metastasis from AFM Image Processing of Histological Sections 14
Efficacy of PARP inhibitors in advanced high-grade serous ovarian cancer according to BRCA domain mutations and mutation type 14
Economic assessment of NGS testing workflow for NSCLC in a healthcare setting 14
Analytical Performance of Next-Generation Sequencing and RT-PCR on Formalin-Fixed Paraffin-Embedded Tumor Tissues for PIK3CA Testing in HR+/HER2− Breast Cancer 13
Circulating biomarkers as predictors of response to immune checkpoint inhibitors in NSCLC: are we on the right path? 13
Epidermal Growth Factor Receptor exon 20 insertion variants in Non-Small Cell Lung Cancer patients 13
Think “HER2” different: integrative diagnostic approaches for HER2-low breast cancer 12
Integrating the Idylla™ System Alongside a Real-Time Polymerase Chain Reaction and Next-Generation Sequencing for Investigating Gene Fusions in Pleural Effusions from Non-Small-Cell Lung Cancer Patients: A Pilot Study 12
Correction: Efficacy of continuous EGFR-inhibition and role of Hedgehog in EGFR acquired resistance in human lung cancer cells with activating mutation of EGFR 12
FGFR2 testing in cholangiocarcinoma: translating molecular studies into clinical practice 12
Homologous Recombination Deficiency in Ovarian Cancer: from the Biological Rationale to Current Diagnostic Approaches 11
Harnessing the potential of genomic characterization of mutational profiles to improve early diagnosis of lung cancer 11
The Impact of potential ‘confounders’ on the diagnostic sensitivity of circulating free DNA in management of FIT+ patients: a pilot study 11
ERBB2 VARIANTS DISTRIBUTION IN NON-SMALL CELL LUNG CANCER: AN ITALIAN REAL-WORLD EXPERIENCE 11
Understanding EGFR heterogeneity in lung cancer 11
Pathology in non-small cell lung cancer: evolving scenario 9
Genomic profiling of tissue and blood predicts survival outcomes in patients with resected pleural mesothelioma 9
Recent advances in the use of liquid biopsy for the diagnosis and treatment of lung cancer 8
A Cross-Sectional Study of Variant Interpretation and Reporting of NGS Data Using Tertiary Analysis Software: Navify® Mutation Profiler 8
RNA-Based Assays 8
B7-H3/CD276 Inhibitors: Is There Room for the Treatment of Metastatic Non-Small Cell Lung Cancer? 8
Clinical utility of ctDNA by amplicon based next generation sequencing in first line non small cell lung cancer patients 7
Totale 2.768
Categoria #
all - tutte 15.078
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.078


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202067 0 0 0 0 0 0 4 36 1 5 18 3
2020/2021166 4 0 4 0 7 36 15 35 20 11 20 14
2021/2022396 26 13 11 4 4 7 3 47 13 45 102 121
2022/2023643 74 45 26 38 79 82 2 75 106 41 65 10
2023/2024554 23 88 37 23 35 39 19 61 17 54 91 67
2024/2025832 156 163 13 33 85 142 240 0 0 0 0 0
Totale 2.798